In this brochure, Dr. Doorenbos, by dividing cholera vibrios into two definite types, viz, the epidemic and the endemic, attempts to reconcile and explain the many diverse and puzzling observations and findings that have been made at different times, and in different countries and circumstances, regarding the cholera vibrio. While most will question the justifiability of this division in the pr...

Introduction. Non-O1/non-O139 is a rare strain of Vibrio cholera that has been documented to cause significant morbidity and mortality in the immunosuppressed population. Case Presentation. A patient with multiple myeloma develops non-O1/non-O139 Vibrio cholera septicemia, leading to multiorgan failure and ultimately death. Discussion. An exceedingly rare strain of Vibrio cholera, non-O1/non-O1...

Significance Two major serotypes of Vibrio cholerae circulate globally and cause pandemic cholera, but how infection or vaccination with each serotype impacts immune responses subsequent protection against future by the pathogen is not well-known. We engineered matched variants a new oral cholera vaccine candidate, HaitiV, to investigate effect variation on immunogenicity protective efficacy. O...

A differential medium designed for rapid presumptive identification of Vibrio cholerae was described and shown to be useful for enumeration of viable cholera vibrios in the presence of other intestinal bacteria.

the role of enterotoxigenic e.coli as a causative agent in diarrheal disease was studied among 100 cases of infant and children 0-2 years of age. routine bacteriological methods were used for identification enteropathogenic e.coli, salmonella, shigella and vibrio cholera. the ability of e.coli strains to produce toxin was assayed in animal models (rebbit-ileal loop and suckling mice) and in tis...

Vibrio cholerae, a Gram-negative pathogen autochthonous to the aquatic environment, is the causative agent of cholera. Here, we report the complete genome sequence of V. cholerae G4222, a clinical isolate from South Africa.

f B. M. PAUL 'o,n the Cholera Bacteriological Enquiry, Indian esca,ch Fund Association, School of Tropical Medicine, Calcutta) Cholera vaccine is extensively used foi Prophylaxis, particularly during epidemics of cholera and in endemic areas of the disease. 1 here are three main sources of cholera vaccine, vaccines prepared by certain recognized oratories, the vaccines prepared by local commerc...

Cholera continues to remain a major public health threat around the globe. Understanding ecology, evolution, and environmental adaptation of causative agent Vibrio cholerae tracking emergence novel lineages with pathogenic potential are essential combat problem.

Choi^ra is almost universally attributed to the cholera vibrio, first discovered by Koch in 1883, and accepted, though not entirely without faint murmurs of questioning-, since. A doubt seems always to have existed as to the actual role played by t'he cholera vibrio, partly owing to the fact that a disease resembling cholera cannot be produced in experimental animals. Whilst to a certain extent...

Vibrio cholerae O1 El Tor variant strains produced much more cholera toxin than did prototype El Tor strains. The amount of cholera toxin produced by El Tor variant strains both in vitro and in vivo was more or less equivalent to that produced by classical strains.